BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21353167)

  • 1. Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
    Rickles DJ
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1280; author reply 1280-1. PubMed ID: 21353167
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "Integrated prostate cancer centers and overutilization of IMRT: a close look at fee-for-service medicine in radiation oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).
    Zimberg SH; Olsson CA
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1607; author reply 1607-8. PubMed ID: 21092840
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.
    Falit BP; Gross CP; Roberts KB
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1285-8. PubMed ID: 20338470
    [No Abstract]   [Full Text] [Related]  

  • 4. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
    Albertini F; Lomax AJ; Hug EB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
    [No Abstract]   [Full Text] [Related]  

  • 5. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
    Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
    [No Abstract]   [Full Text] [Related]  

  • 6. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
    Vordermark D; Guckenberger M; Baier K; Markert K
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
    [No Abstract]   [Full Text] [Related]  

  • 7. The paradox of multidisciplinary care.
    Potters L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):20-2. PubMed ID: 22901419
    [No Abstract]   [Full Text] [Related]  

  • 8. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (Int J Radiat Oncol Biol Phys 2003;56:184-191).
    Macias V
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):320-1; author reply 321-2. PubMed ID: 15093933
    [No Abstract]   [Full Text] [Related]  

  • 10. Does image-guided radiotherapy (IG-IMRT) improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT: In regard to Chung et al. (Int J Radiat Oncol Biol Phys 2008. In press).
    Jothybasu KS; Bahl A; Subramani V; Sharma DN; Rath GK
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1273; author reply 1273. PubMed ID: 18954726
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-rate effects when estimating risks for second malignancies: in regard to Fontenot et al (Int J Radiat Oncol Biol Phys 2009;74:616-622).
    Paganetti H; Athar BS; Bednarz B
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1624; author reply 1624-5. PubMed ID: 19931743
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to "the impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy" (Int J Radiat Oncol Biol Phys 2011;79:379-384).
    Oymak E; Onal C
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1603; author reply 1603-4. PubMed ID: 21740997
    [No Abstract]   [Full Text] [Related]  

  • 13. Commissioning and quality assurance of RapidArc radiotherapy delivery system: in regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72;575-581): Absence of data does not constitute proof; the proof is in tasting the pudding.
    Mehta M; Hoban P; Mackie TR
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):4-6; discussion 8-9. PubMed ID: 19695432
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to "Dosimetric study of pelvic radiotherapy for high-risk prostate cancer." (Int J Radiat Oncol Biol Phys 2009;75:994-1002).
    Dimitroyannis DA
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):315; author reply 316. PubMed ID: 20708490
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Magical protons?" editorial by Goitein (Int J Radiat Oncol Biol Phys 2008;70:654-656).
    Fowler JF
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1270-1. PubMed ID: 18954721
    [No Abstract]   [Full Text] [Related]  

  • 16. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 17. IMRT for gastric cancer: what is its full potential? In regard to Alani et al. (Int J Radiat Oncol Biol Phys 2009;74:562-566).
    Lohr F; Boda-Heggemann J; Mai SK; Wenz F
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):635; author reply 635-6. PubMed ID: 19735895
    [No Abstract]   [Full Text] [Related]  

  • 18. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Cheung MR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on editorial "Magical protons" by Dr. Michael Goitein (Int J Radiat Oncol Biol Phys 2008;70:654-656) and in reply to Dr. Fowler.
    Withers HR; Peters LJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1271. PubMed ID: 18954723
    [No Abstract]   [Full Text] [Related]  

  • 20. In regard to "Dose escalation in the radiation therapy of prostate cancer" (Int J Radiat Oncol Biol Phys 2011;80:1289-1291).
    Bowes D; Crook J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1317-8. PubMed ID: 22385710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.